Clinical Research Directory
Browse clinical research sites, groups, and studies.
LATe Cerclage in High-risk Pregnancies (LATCH)
Sponsor: Thomas Jefferson University
Summary
The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Official title: Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
329
Start Date
2023-11-10
Completion Date
2029-02
Last Updated
2025-04-16
Healthy Volunteers
Yes
Conditions
Interventions
Cervical cerclage
Transvaginal cervical cerclage placed between 24 0/7 - 26 6/7 weeks of gestation.
Vaginal Suppository Progesterone
Continuing or initiation of vaginal progesterone 200mg daily until 36 weeks of gestation.
Locations (1)
Thomas Jefferson University
Philadelphia, Pennsylvania, United States